.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
US Department of Justice
Dow
US Army
Queensland Health
Daiichi Sankyo
QuintilesIMS
Cerilliant
Mallinckrodt
Johnson and Johnson

Generated: November 18, 2017

DrugPatentWatch Database Preview

IMPLANON Drug Profile

« Back to Dashboard

What is the patent landscape for Implanon, and when can generic versions of Implanon launch?

Implanon is a drug marketed by Organon Usa Inc and is included in one NDA. There is one patent protecting this drug.

This drug has twenty-two patent family members in nineteen countries and four supplementary protection certificates in four countries.

The generic ingredient in IMPLANON is etonogestrel. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.

Pharmacology for IMPLANON

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: IMPLANON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: IMPLANON

Country Document Number Estimated Expiration
New Zealand556490► Subscribe
Taiwan200640518► Subscribe
Norway20073748► Subscribe
South Africa200705955► Subscribe
Australia2006207455► Subscribe
Ukraine89518► Subscribe
China101151062► Subscribe
European Patent Office1841493► Subscribe
South Korea101278854► Subscribe
Japan2008528085► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: IMPLANON

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
80027Netherlands► SubscribePRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825
9C0041Belgium► SubscribePRODUCT NAME: ETONOGESTREL; NATL. REGISTRATION NO/DATE: 52 IS 296 F 14 19990531; FIRST REGISTRATION: NL RVG 21168 19980825
/1999Austria► SubscribePRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825
C/GB99/044United Kingdom► SubscribePRODUCT NAME: ETONOGESTREL; REGISTERED: NL RGV21168 19980825; UK 00065/0161 19990609
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Moodys
Fuji
QuintilesIMS
Queensland Health
Cantor Fitzgerald
US Department of Justice
UBS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot